释 义 n. 艾乐替尼；阿雷替尼
例 句 ALK mutation analysis was conducted on cell-free DNA from 49 of these patients who subsequently progressed on alectinib. 我们对后服用艾乐替尼的49例患者的细胞游离DNA进行ALK突变分析。
作者： Johannes Noé
期刊：J Thorac Oncol
Baseline characteristics were generally balanced across patient subgroups. At baseline, 34 distinct ALK mutations were identified in 48 of 187 patients (25.7%). Median investigator-assessed progression-free survival was longer in patients without ALK single-nucleotide variants (n = 138) versus those with (n = 48): 10.2 months (95% confidence interval [CI]: 8.1-14.3) versus 5.6 months (95% CI: 4.5-10.9), respectively.